Welcome to the Rare & Genetic Kidney Disease Blog
Click to explore all of our content related to the 2026 event.
Exclusive interview Jennifer McKenzie from Boehringer Ingelheim on Rare Nephrology
Learn more about her perspective on the field of rare and genetic kidney diseases.
What to Expect On Site at the 6th Rare & Genetic Kidney Disease Drug Development Summit
On Site Experience
Industry Challenges Across Rare Nephrology
Explore the top industry challenges and how the summit can help to overcome this.
Biomarkers, Endpoints, and Evidence Generation in Rare & Genetic Kidney Diseases
Navigating Evolving Expectations
Who is Attending the 6th Rare & Genetic Kidney Disease Summit?
Explore the Biopharma Leaders Prioritizing Rare Kidney Diseases
The State of Rare and Genetic Kidney Disease Research
Why collaboration is becoming essential in rare and genetic kidney disease development.
Explore the Agenda
Hear the latest breakthroughs in biomarker validation, surrogate endpoints, and clinical trial design through a packed agenda featuring 3 expert panel discussions, 3 pre-conference workshops, 2 interactive roundtables, and 12+ data-driven case study presentations.
Partner With Us
Position yourself alongside leading solution providers supporting rare and genetic kidney disease pipelines. Whether your expertise lies in preclinical or clinical research, novel biomarkers for diagnosis, stratification or monitoring, imaging, or genetic testing, ensure your brand is at the center of key conversations around clinical development, endpoint validation, and trial execution
Join Biopharma Experts
Engage with a uniquely focused audience of rare and genetic kidney disease decision-makers and be part of high-value conversations with like-minded attendees across all stages of drug development, building critical connections through dedicated networking opportunities